Multiple chemical sensitivities: Review

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 15, Issue 4, 2007, Pages 274-280

  Das Munshi, Jayati ^a   Rubin, G James ^a   Wessely, Simon ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Functional somatic syndromes; Idiopathic environmental intolerance; IEI; MCS; Multiple chemical sensitivity

Indexed keywords

ANTIDEPRESSANT AGENT;

CLINICAL FEATURE; COMORBIDITY; ECOLOGY; HUMAN; IATROGENIC DISEASE; MENTAL DISEASE; MULTIPLE CHEMICAL SENSITIVITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TOTAL QUALITY MANAGEMENT;

HUMANS; MULTIPLE CHEMICAL SENSITIVITY;

EID: 34447331399     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e328259c360     Document Type: Review

References (82)

1. Randolph TG. Human ecology and susceptibility to the chemical environment. Springfield USA: Charles Thomas; 1962.
2. Anderson JA, Chai H, Claman HN, et al. Position statement on clinical ecology. J Allergy Clin Immunol 1986; 78:269-271.
3. Council on Scientific Affairs AMA. Clinical ecology. JAMA 1992; 268:3465-3467.
4. American College of Occupational and Environmental Medicine. Multiple Chemical Sensitivities: idiopathic environmental intolerance [position statement]. ACOEM Rep 1999; 1-3.
5. Baines CJ, McKeown-Eyssen GE, Riley N, et al. University of Toronto case-control study of multiple chemical sensitivity-3: intra-erythrocytic mineral levels. Occup Med 2007; 57:137-140.
6. Baines CJ, McKeown-Eyssen GE, Riley N, et al. Case-control study of multiple chemical sensitivity, comparing hematology, biochemistry, vitamins and serum volatile organic compound measures. Occup Med 2004; 54:408-418.
7. Kronfol Z, Nasrallah HA, Chapman S, House JD. Depression, cortisol metabolism, and lymphocytopenia. J Affect Disord 1985; 9:169-173.
8. Rief W, Pilger F, Ihle D, et al. Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res 2001; 105:165-174.
9. Cullen M. Workers with multiple chemical sensitivities. Occupational Medicine: State of the Art Reviews 1987; 2.
10. Multiple Chemical Sensitivity: a 1999 consensus. Arch Environ Health 1999; 54:147-149.
11. Association of Occupational and Environmental Clinics. Advancing the understanding of Multiple Chemical Sensitivity. Proceedings of the AOEC Workshop on Multiple Chemical Sensitivity. Toxicol Ind Health 1992; 8.
12. International Programme on Chemical Safety/World Health Organization (IPCS/WHO). Conclusions and recommendations for a workshop on multiple chemical sensitivities (MCS). Regul Toxicol Pharmacol 1996; 24:S188-S189.
13. Simon GE, Daniell W, Stockbridge H, et al. Immunologic, psychological, and neuropsychological factors in Multiple Chemical Sensitivity. Ann Intern Med 1993; 119:97-103.
14. Hausteiner C, Bornschein S, Hansen J, et al. Self-reported chemical sensitivity in Germany: a population-based survey. Int J Hyg Environ Health 2005; 208:271-278.
15. Carlsson F, Karlson B, Orbaek P, et al. Prevalence of annoyance attributed to electrical equipment and smells in a Swedish population, and relationship with subjective health and daily functioning. Public Health 2005; 119:568-577.
16. Caress SM, Steinemann AC. Prevalence of multiple chemical sensitivities: a population based study in the southeastern United States. Am J Public Health 2004; 94:746-747.
17. Caress SM, Steinemann AC. A review of a two phase population study of Multiple Chemical Sensitivities. Environ Health Perspect 2003; 111:1490-1497.
18. Levallois P, Neutra R, Lee G, Hristova L. Study of self reported hypersensitivity to electromagnetic fields in California. Environ Health Perspect 2002; s110:619-623.
19. Kreutzer R, Neutra RR, Lashuiay N. Prevalence of people reporting sensitivities to chemicals in a population-base survey. Am J Epidemiology 1999; 150:1-12.
20. Meggs WJ, Dunn KA, Bloch RM, et al. Prevalence and nature of allergy and chemical sensitivity in a general population. Arch Environ Health 1996; 51:275-282.
21. Bell IR, Schwartz GE, Peterson JM, Amend D. Self-reported illness from chemical odors in young adults without clinical syndromes or occupational exposures. Arch Environ Health 1993; 48:6-13.
22. Thomas HV, Stimpson NJ, Weightman AL, et al. Systematic review of multisystem conditions in Gulf War veterans. Psychol Med 2006; 36:735-747. Systematic review of studies examining multisystem conditions in Gulf War veterans. Veterans deployed to the Gulf were about three-and-a-half times more likely to report MCS than veterans who were not deployed. This review does not examine biological or socio-cultural mechanisms which could account for the association.
23. Reid S, Hotopf M, Hull L, et al. Multiple chemical sensitivity and Chronic Fatigue Syndrome in British Gulf War veterans. Am J Epidemiol 2001; 153:604-609.
24. Black DW, Doebbeling BN, Voelker MD, et al. Multiple Chemical Sensitivity Syndrome: symptom prevalence and risk factors in a military population. Arch Intern Med 2000; 160:1169-1176.
25. Shorter E. Multiple chemical sensitivity: pseudodisease in historical perspective. Scand J Work Environ Health 1997; 23:35-42.
26. Fletcher CM. Environmental sensitivity: equivocal illness in the context of place. Transcult Psychiatry 2006; 43:86-105.
27. Bornschein S, Forstl H, Zilker T. Idiopathic environmental intolerances (formerly multiple chemical sensitivity) psychiatric perspectives. J Intern Med 2001; 250:309-321.
28. Schrader H, Obelieniene D, Bovim G, et al. Natural evolution of late whiplash syndrome outside the medicolegal context. Lancet 1996; 347:1207-1211.
29. Mouterde O. Myalgic encephalomyelitis in children. Lancet 2001; 357:562.
30. Das-Munshi J, Rubin J, Wessely S. Multiple Chemical Sensitivities: a systematic review of provocation studies. J Allerg Clin Immunol 2006; 118:1257-1264. Systematic review of all provocation studies which examined responses of people reporting chemical sensitivities after they were provoked with active and placebo substances. Blinding in the majority of studies, including those studies claiming to incorporate 'double blind' methodologies, was poor. In those studies which did incorporate adequate blinding, there was no evidence to suggest that people reporting chemical sensitivities were able to differentiate active over sham exposures compared with chance. This suggests that responses reported by people with MCS are not associated with biological properties of implicated chemicals.
31. Leznoff A. Provocative challenges in patients with multiple chemical sensitivity. J Allerg Clin Immunol 1997; 99:438-442.
32. Georgellis A, Lindelof B, Lundin A, et al. Multiple chemical sensitivities in painters: a controlled provocation study. Int J Hyg Environ Health 2003; 206:531-538.
33. Dalton P. Cognitive influences on health symptoms from acute chemical exposure. Health Psychol 1999; 18:579-590.
34. Lorber W, Mazzoni G, Kirsch I. Illness by suggestion: expectancy, modeling, gender in the production of psychosomatic symptoms. Ann Behav Med 2007; 33:112-116. Healthy participants were randomly assigned to two groups to either inhale or not inhale an inert placebo (odourless ambient air). Participants were also assigned to inhale this placebo in the presence of a female 'confederate' who role-played experiencing specified symptoms after also inhaling the placebo. Individuals assigned to the inhalation group reported more specified symptoms than the control group; female participants who inhaled the placebo in the presence of the confederate reported more specified symptoms. This effect was not observed in male participants.
35. Winters W, Devriese S, Van Diest I, et al. Media warnings about environmental pollution facilitate the acquisition of symptoms in response to chemical substances. Psychosom Med 2003; 65:332-338.
36. Van den Bergh O, Kempynck PJ, Van de Woestijne KP, et al. Respiratory learning and somatic complaints: a conditional approach using CO2-enriched air inhalation. Behav Res Ther 1995; 33:517-523.
37. Van den Bergh O, Stegen K, Van de Woestijne KP. Learning to have psychosomatic complaints: conditioning of respiratory behaviour and somatic complaints in psychosomatic patients. Psychosom Med 1997; 59:13-23.
38. Van Diest I, De Peuter S, Piedfort K, et al. Acquired lightheadness in response to odors after hyperventilation. Psychosom Med 2006; 68:340-347. See text; this study not only confirms that adverse responses to odours may be easily 'learnt' in otherwise healthy volunteers, but also, as the authors conclude, that such a model might also account for the paradox that both exposure and avoidance of chemicals lead to a reduction in adverse responses in people reporting MCS.
39. Devriese S, Winters W, Stegen K, et al. Generalisation of acquired somatic symptoms in response to odors: a pavlovian perspective on Multiple Chemical Sensitivity. Psychosom Med 2000; 62:751-759.
40. Lange LJ, Fleming R. Cognitive influences on the perception of somatic change during a feigned chemical release. Journal of Applied Social Psychology 2005; 35:463-486.
41. Osterberg K, Persson R, Karlson B, et al. Personality, mental distress, and subjective health complaints among persons with environmental annoyance. Hum Exp Toxicol 2007; 26:231. Cross-sectional survey examining trait anxiety/neuroticism and work satisfaction amongst 'smell annoyed', 'electrically annoyed' and 'smell and electrically annoyed' people. Although the 'smell annoyed' group showed minor elevations on the trait anxiety scale compared with the other two groups, all three groups reported low job satisfaction, more fatigue after work and an unfulfilled need for recovery.
42. Marmot AF, Eley J, Stafford M, et al. Building health: an epidemiological study of 'sick building syndrome' in the Whitehall II study. Occup Environ Med 2006; 63:283-289.
43. Smith S, Sullivan K. Examining the influence of biological and psychological factors on cognitive performance in Chronic Fatigue Syndrome: a randomized, double-blind, placebo-controlled, crossover study. Int J Behav Med 2003; 10:162-173.
44. Reid S, Hotopf M, Hull L, et al. Reported chemical sensitivities in a health survey of United Kingdom military personnel. Occup Environ Med 2002; 59:196-198.
45. Unwin C, Blatchley N, Coker W, et al. Health of UK servicemen who served in Persian Gulf War. Lancet 1999; 353:169-178.
46. Bornschein S, Hausteiner C, Zilker T, Forstl H. Psychiatric and somatic disorders and multiple chemical sensitivity (MCS) in 264 'environmental patients'. Psychol Med 2002; 32:1387-1394.
47. Dietal A, Jordan L, Muhlingaus T, et al. Psychiatric disorders of environmental outpatients: results of the standardized psychiatric interview (CIDI) from the German multicenter study on Multiple Chemical Sensitivity (MCS). Psychother Psychosom Med Psychol 2006; 56:162-171.
48. Bailer J, Witthoft M, Paul C, et al. Evidence for overlap between idiopathic environmental intolerance and somatoform disorders. Psychosom Med 2005; 67:921-929.
49. Bornschein S, Hausteiner C, Konrad F, et al. Psychiatric morbidity and toxic burden in patients with environmental illness: a controlled study. Psychosom Med 2006; 68:104-109.
50. Staudenmayer H, Phillips S. MMPI-2 validity, clinical and content scales, and the Fake Bad Scale for personal injury litigants claiming idiopathic environmental intolerance. J Psychosom Res 2007; 62:61-72.
51. Binder LM, Storzbach D, Salinsky MC. MMPI-2 profiles of persons with multiple chemical sensitivity. Clin Neuropsychol 2006; 20:848-857.
52. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999; 354:936-939.
53. Wessely S, White PD. In debate: there is only one functional somatic syndrome. Br J Psychiatry 2004; 185:95-96.
54. Engel CE. Explanatory and pragmatic perspectives regarding idiopathic physical symptoms and related syndromes. CNS Spectrums 2006; 11:225-232.
55. Hausteiner C, Mergeay A, Bornschein S, et al. New aspects of psychiatric morbidity in idiopathic environmental intolerances. J Occup Environ Med 2006; 48:76-82.
56. McIntyre RS, Konarski JZ, Soczynska JK, et al. Medical comorbidity in bipolar affective disorder: implications for functional outcomes and health service utilization. Psychiatr Serv 2006; 57:1140-1144.
57. Dumit J. Illnesses you have to fight to get: facts as forces in uncertain, emergent illnesses. Soc Sci Med 2006; 62:577-590.
58. Lipson JG, Doiron N. Environmental issues and work: women with Multiple Chemical Sensitivities. Health Care Women Int 2006; 27:571-584.
59. Gibson PR, Elms ANM, Ruding LA. Perceived treatment efficacy for conventional and alternative therapies reported by people with multiple chemical sensitivities. Environ Health Perspect 2003; 111:1498-1504.
60. Taylor JP, Krondl MM, Spidel M, Csima A. Dietary adequacy of the rotary diversified diet as a treatment for 'environmental illness'. Can J Diet Pract Res 2002; 63:198-201.
61. Brusko CS, Marten JT. Ketoconazole hepatotoxicity in a patient treated for environmental illness and systemic candidiasis. DICP 1991; 25:1321-1325.
62. Binkley K, King N, Poonai N, et al. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7. J Allergy Clin Immunol 2001; 107:887-890.
63. Poonai N, Antony MM, Binkley KE, et al. Carbon dioxide inhalation challenges in idiopathic environmental intolerance. J Allergy Clin Immunol 2000; 105:358-363.
64. Poonai NP, Antony MM, Binkley KE, et al. Psychological features of subjects with idiopathic environmental intolerance. J Psychosom Res 2001; 51:537-541.
65. Tarlo SM, Poonai N, Binkley K, et al. Responses to panic induction procedures in subjects with multiple chemical sensitivity/idiopathic environmental intolerance: understanding the relationship with panic disorder [review]. Environ Health Perspect 2002; 110 (Suppl 4):669-671.
66. Van den Bergh O, Stegen K, Van Diest I, et al. Acquisition and extinction of somatic symptoms in response to odors: a Pavlovian perspective on multiple chemical sensitivity. Occup Environ Med 1999; 56:295-301.
67. Stenn P, Binkley K. Successful outcome in a patient with chemical sensitivity: treatment with psychological desensitization and selective serotonin reuptake inhibitor. Psychosomatics 1998; 39:547-550.
68. Ronnback AP, Jarvholm B. Successful use of a selective serotonin reuptake inhibitor in a patient with multiple chemical sensitivities. Acta Psychiatr Scand 1997; 96:82-83.
69. Boxer PA. Outpatient treatment for 'Multiple Chemical Sensitivities'. J Clin Psychiatry 1994; 55:316.
70. Guglielmi RS, Cox DJ, Spyker DA. Behavioral treatment of phobic avoidance in multiple chemical sensitivity. J Behav Ther Exp Psychiatry 1994; 25:197-209.
71. Amundsen MA, Hanson NP, Bruce BK, et al. Odor Aversion or Multiple Chemical Sensitivities: recommendation for a name change and description of successful behavioral medicine treatment. Regul Toxicol Pharmacol 1996; 24:S116-S118.
72. Temple S. A case of Multiple Chemical Sensitivities: cognitive therapy for somatization disorder and metaworry. Journal of Cognitive Psychotherapy 2003; 17:267-277.
73. Lacour M, Zunder T, Dettenkofer M, et al. An interdisciplinary therapeutic approach for dealing with patients attributing chronic fatigue and functional memory disorders to environmental poisoning: a pilot study. Int J Hyg Environ Health 2002; 8:339-346.
74. Haller E. Successful management of patients with 'multiple chemical sensitivities' on an inpatient psychiatric unit. J Clin Psychiatry 1993; 54:196-199.
75. Staudenmayer H. Psychological treatment of psychogenic idiopathic environmental intolerance. Occup Med 2000; 15:627-646.
76. Deale A, Chalder T, Wessely S. Illness beliefs and treatment outcome in chronic fatigue syndrome. J Psychosom Res 1998; 45:77-83.
77. Herr CE, Kopka I, Mach J, et al. Interdisciplinary diagnostics in environmental medicine: findings and follow-up in patients with chronic medically unexplained health complaints. Int J Environ Health 2004; 207:31-44.
78. Puddicombe D. Catching whiff of a scent ban: city looking to curtail fake fragrances. Ottawa Sun; 27 May, 2006; 5.
79. Bailer J, Witthoft M, Bayerl C, Rist F. Syndrome stability and psychological predictors of symptom severity in idiopathic environmental intolerance and somatoform disorders. Psychol Med 2007; 37:271-281. Prospective study of 152 people fulfiling criteria for MCS, of which 140 were followed up 1 year later; 91.8% of participants reporting MCS at baseline met case criteria for MCS 1 year later, confirming that MCS is extremely temporally stable. High proportions of the MCS group were functionally impaired (75.5% reported difficulties shopping in stores or eating in restaurants and 79.6% reported taking special precautions at home) and 22.4% had lost a job or had stopped working at follow-up. Trait-negative affectivity and somatic symptom attribution continued to predict symptom severity in the MCS group at 1 year. Prominent cognitions of environmental threat, as well as the tendency to focus on bodily sensations and interpret these as pathological, were also found to be strongly associated with MCS caseness at 1-year follow-up.
80. Black DW, Okiishi C, Schlosser S. A nine year follow up of people diagnosed with multiple chemical sensitivities. Psychosomatics 2000; 41:253-261.
81. Mayou R, Kirmayer LJ, Simon G, et al. Somatoform disorders: time for a new approach in DSM-IV. Am J Psychiatry 2005; 162:847-855.
82. Huibers MJH, Wessely S. The act of diagnosis: pros and cons of labelling chronic fatigue syndrome. Psychol Med 2006; 36:895-900. Narrative review of the literature on Chronic Fatigue Syndrome which, as in the case of MCS, highlights the conflict between medical models of CFS and user-led notions of CFS, in the absence of an established organic cause for the condition. The authors propose that the issue in the management of these patients should not be one of labelling but one of engendering a positive therapeutic encounter in which patients are encouraged to take an active role in their recovery without attributing blame, and are given accurate nonpartial advice around the condition. The authors also suggest that whilst it might be beneficial to the therapeutic alliance to acknowledge the patient's distress, this should be done sensitively without reinforcing sick role beliefs or 'maladaptive illness beliefs'.